Ocugen (OCGN) Total Liabilities (2014 - 2026)
Ocugen (OCGN) reported Total Liabilities of $51.1 million for Q1 2026, up 5.26% on a YoY basis from $48.5 million in Q1 2025, and down 8.23% quarter-over-quarter from $55.7 million in Q4 2025.
Ocugen (OCGN) Total Liabilities (2014 - 2026) Analysis & Trends
Ocugen has reported Total Liabilities for 13 years, with the latest figure at $51.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 5.26% year-over-year to $51.1 million; the trailing twelve-month figure through Mar 2026 stood at $51.1 million (up 5.26% YoY), and the FY2025 full-year result was $55.7 million, up 5.44% from the prior year.
- Total Liabilities for Q1 2026 stood at $51.1 million, down from $55.7 million in the prior quarter.
- The five-year high for Total Liabilities was $55.7 million in Q4 2025, with the low at $16.2 million in Q1 2022.
- Historically, Total Liabilities has averaged $35.0 million across 5 years, with a median of $30.6 million in 2022.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 248.5% — and 2024, when it sank 31.42%.
- Ocugen's Total Liabilities stood at $34.7 million in 2022, then slumped by 30.79% to $24.0 million in 2023, then surged by 120.2% to $52.8 million in 2024, then gained by 5.44% to $55.7 million in 2025, then declined by 8.23% to $51.1 million in 2026.
- The last three Total Liabilities figures came in at $51.1 million (Q1 2026), $55.7 million (Q4 2025), and $54.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 51.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.10 Mn |
| Dec 31, 2025 | 55.68 Mn |
| Sep 30, 2025 | 54.06 Mn |
| Jun 30, 2025 | 50.54 Mn |
| Mar 31, 2025 | 48.55 Mn |
| Dec 31, 2024 | 52.81 Mn |
| Sep 30, 2024 | 21.31 Mn |
| Jun 30, 2024 | 23.62 Mn |
| Mar 31, 2024 | 21.53 Mn |
| Dec 31, 2023 | 23.98 Mn |
| Sep 30, 2023 | 24.89 Mn |
| Jun 30, 2023 | 29.73 Mn |
| Mar 31, 2023 | 31.40 Mn |
| Dec 31, 2022 | 34.65 Mn |
| Sep 30, 2022 | 30.55 Mn |
| Jun 30, 2022 | 23.61 Mn |
| Mar 31, 2022 | 16.21 Mn |
| Dec 31, 2021 | 9.94 Mn |
| Sep 30, 2021 | 9.20 Mn |
| Jun 30, 2021 | 7.84 Mn |